Guardant Health, Inc. (NASDAQ:GH) Q2 2024 Results Earnings Conference Call August 7, 2024 4:30 PM ET

Company Participants

Zarak Khurshid - Vice President of Investor Relations
Helmy Eltoukhy - Chairman and co-Chief Executive Officer
AmirAli Talasaz - Co-Chief Executive Officer
Michael Bell - Chief Financial Officer

Conference Call Participants

Mark Massaro - BTIG
Daniel Brennan - TD Cowen
Puneet Souda - Leerink Partners
Tejas Savant - Morgan Stanley
Bill Bonello - Craig-Hallum
Jack Meehan - Nephron Research
Daniel Arias - Stifel Financial
Doug Schenkel - Wolfe Research
Patrick Donnelly - Citigroup
Tycho Peterson - Jefferies

Operator

Good afternoon. Thank you for attending today's Guardant Health Q2 2024 Earnings Call. My name is Tamiya and I will be your moderator for today's call. All lines will be muted during the presentation portion of the call with an opportunity for questions and answers at the end. [Operator Instructions].

I would now like to pass the conference over to your host, Zarak Khurshid, Vice President of Investor Relations. You may proceed.

Zarak Khurshid

Thank you. Earlier today, Guardant Health released financial results for the quarter ended June 30, 2024. Joining me today from Guardant are Helmy Eltoukhy, Co-CEO; AmirAli Talasaz, Co-CEO; and Mike Bell, Chief Financial Officer.

Before we begin, I'd like to remind you that, during this call, management will make forward-looking statements within the meaning of federal securities laws. These statements involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated.

This call will also include a discussion of non-GAAP financial measures, which are adjusted to exclude certain specific items. Additional information regarding material risks and uncertainties, as well as reconciliation to the most directly comparable GAAP financial measures are available in the press release Guardant issued today, as well as in our 10-K and other filings with the SEC.

Guardant disclaims any intention or obligation to update or revise financial projections and forward-looking statements whether because of new information, future events or otherwise. The information in this conference call is accurate only as of the live broadcast.

With that, I'd like to turn the call over to Helmy.

Helmy Eltoukhy

Thanks, Zarak. Good afternoon, and thank you for joining our second quarter 2024 earnings call. We founded Guardant Health with a bold mission to conquer cancer with data. With our comprehensive suite of tests, we are now truly transforming patient lives across the continuum of care.